Lu AG09222
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lu AG09222, covering 2024-02-08 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments [Phase 2]